XARELTO® significantly reduces the risk of stroke in people with AFib‡ notcaused by a heart valve problem.
What is XARELTO®?
XARELTO® belongs to a group of medicines called direct oral anticoagulants, or DOACs† for short. Like other DOACs, XARELTO® has no known dietary restrictions and no requirements for frequent blood tests.
XARELTO® significantly reduces the risk of stroke in people with AFib‡ notcaused by a heart valve problem.
In a clinical trial, over 96% of people who took XARELTO® remained stroke-free.§
XARELTO® offers 24-hour stroke-risk reduction with just one pill a day.*
In a clinical trial comparing XARELTO® to warfarin for reducing the risk of AFib-related stroke, 99% of people taking XARELTO® did not experience bleeding into the brain, which can be serious. However, overall major bleeding was similar and gastrointestinal bleeding was about 1% higher.
*Taken with the evening meal.
†DOACs=direct oral anticoagulants.
‡AFIB=atrial fibrillation
§Rate of first occurrence of stroke was 3.8% for XARELTO® versus 4.3% for warfarin.
Take one 15-mg or 20-mg tablet
once a day, with dinner
![]()
Tablets shown not actual size
How do you take XARELTO®?
Are there any side effects associated with XARELTO® in adults?
Side effects of XARELTO® :
Your risk of bleeding increases if you take XARELTO® with other medicines that also increase your risk of bleeding, such as:
Always tell your healthcare professional if you experience any side effects while taking XARELTO®—keeping an open and honest conversation going with your healthcare professional will help you get the best care. You can use the Doctor Discussion Guide to help inform your conversation.